Elsevier

Mitochondrion

Volume 10, Issue 1, January 2010, Pages 12-31
Mitochondrion

Review
Energetics, epigenetics, mitochondrial genetics

https://doi.org/10.1016/j.mito.2009.09.006Get rights and content

Abstract

The epigenome has been hypothesized to provide the interface between the environment and the nuclear DNA (nDNA) genes. Key factors in the environment are the availability of calories and demands on the organism’s energetic capacity. Energy is funneled through glycolysis and mitochondrial oxidative phosphorylation (OXPHOS), the cellular bioenergetic systems. Since there are thousands of bioenergetic genes dispersed across the chromosomes and mitochondrial DNA (mtDNA), both cis and trans regulation of the nDNA genes is required. The bioenergetic systems convert environmental calories into ATP, acetyl-Coenzyme A (acetyl-CoA), s-adenosyl-methionine (SAM), and reduced NAD+. When calories are abundant, ATP and acetyl-CoA phosphorylate and acetylate chromatin, opening the nDNA for transcription and replication. When calories are limiting, chromatin phosphorylation and acetylation are lost and gene expression is suppressed. DNA methylation via SAM can also be modulated by mitochondrial function. Phosphorylation and acetylation are also pivotal to regulating cellular signal transduction pathways. Therefore, bioenergetics provides the interface between the environment and the epigenome. Consistent with this conclusion, the clinical phenotypes of bioenergetic diseases are strikingly similar to those observed in epigenetic diseases (Angelman, Rett, Fragile X Syndromes, the laminopathies, cancer, etc.), and an increasing number of epigenetic diseases are being associated with mitochondrial dysfunction. This bioenergetic–epigenomic hypothesis has broad implications for the etiology, pathophysiology, and treatment of a wide range of common diseases.

Introduction

“The modern definition of epigenetics is information heritable during cell division other than the DNA sequence itself” (Feinberg, 2007). Hence, epigenetics is thought to provide a flexible interface between the organism and its environment. Until now, the DNA sequences of interest to biology and medicine have been in the chromosomal DNA, which is transmitted during meiotic and mitotic cell division according to the rules of Gregor Mendel. However, most common metabolic and degenerative diseases and multiple cancers are familial, but are not classically Mendelian in their transmission. Therefore, such “complex diseases” have been attributed to epigenetic changes in response to the environmental change (Feinberg, 2007, Feinberg, 2008).

However, deficiency in energy metabolism has also emerged as an alternative explanation for the etiology of complex diseases over the past 21 years. The primary limiting factor for growth and reproduction of all biological systems is energy and the first reports that mitochondrial DNA (mtDNA) mutations can cause disease (Goto et al., 1990, Holt et al., 1988, Holt et al., 1990, Shoffner et al., 1990, Wallace et al., 2007, Wallace et al., 1988a, Wallace et al., 1988b) have been followed by reports that a broad spectrum of metabolic and degenerative diseases can have a mitochondrial etiology (Wallace et al., 2007). Moreover, environmentally adaptive mtDNA variants have been associated with predisposition to virtually the entire range of common “complex” diseases (Wallace, 2008).

However, similar symptoms imply a common pathophysiology. Therefore, epigenetic and mitochondrial genetic diseases must be interrelated through their impinging on a common function.

To understand nuclear–mitochondrial interactions, we must consider the early stages in the endosymbiontic event that created the eukaryotic cell about 2 billion years ago (Lane, 2002, Lane, 2005, Wallace, 2007). In the beginning, the proto-nucleus–cytosol was limited by energy. This limitation was alleviated by its symbiosis with an oxidative α-protobacterion, the proto-mitochondrion. Therefore, growth and replication of the nucleus became limited by mitochondrial energy production and thus calorie availability. This necessitated the regulation of nuclear replication and gene expression by calorie availability mediated by mitochondrial energetics. This was achieved by coupling modulation of nDNA chromatin structure and function by modification via high energy intermediates: phosphorylation by ATP, acetylation by acetyl-Coenzyme A (Ac-CoA), deacetylation by nicotinamide adenine dinucleotide (NAD+), and methylation by s-adenosyl-methionine (SAM).

Conversely, the nucleus had to develop mechanisms for modulating mitochondrial growth and replication. This was additionally complicated by the successive transfer of genes from the proto-mitochondrial DNA to the nDNA, with the cytosolic translation products being directionally imported back into the mitochondrion (Wallace, 2007). This process proceeded over a billion years with the result that the nDNA-encoded genes of the mitochondrial genome are now dispersed throughout the chromosomes (Wallace, 2007). Therefore, new mechanisms had to evolve to permit the coordinate expression of the mitochondrial genes based on nuclear requirements for energy for growth and reproduction. As a result, this became one of the early driving forces for the evolution of inter-chromosomal coordinate transcriptional regulation.

Over the subsequent 1.2 billion years, the nucleus–cytosol became increasingly specialized in specifying structure while the mitochondrion became entirely dedicated to energy production. Ultimately, this subcellular specialization became sufficiently refined and efficient that it permitted the advent of multicellularity and thus plants and animals (Wallace, 2007). Still, all subsequent tissue development, species radiation, and environmental adaptation were rooted in the fundamental energetic–epigenetic cooperation.

Section snippets

Mitochondrial bioenergetics

Complex structures can only be maintained by the continual flux of energy. Life, therefore, is the interaction between structure, energy, and information, with information required for both structure and energetics (Wallace, 2007).

THe energetic evolution of the epigenome

Prior to the advent of free oxygen in the biosphere, substrate-level phosphorylation was the primary mechanism for generating ATP in non-photosynthetic organisms. After the generation of free oxygen by photosystem II the redox range of biology was greatly expanded and OXPHOS became the most efficient system for generating ATP from the reducing equivalents present in organic molecules (Lane, 2002, Lane, 2005, Wallace, 2007).

Mitochondrial genetic disease

The elucidation of a broad spectrum of mtDNA and nDNA mitochondrial gene mutation diseases has revealed that mitochondrial dysfunction can result in the entire range of clinical phenotypes associated with metabolic and degenerative diseases as well as cancer and aging (Wallace et al., 2007). Mitochondrial diseases have been shown to affect the highly oxidative tissues including the brain, heart, muscle, kidney, and endocrine systems; as well as the metabolic systems resulting in diabetes,

Mitochondrial explanations for epigenetic diseases

Therefore, mitochondrial gene defects can result in virtually all of the symptoms associated with the common “complex” diseases, confirming the importance of mitochondrial bioenergetics in health. Since mitochondrial metabolism also regulates the substrates for epigenomic regulation, it follows that changes in mitochondrial metabolism may also perturb the epigenomic state. Furthermore, in cells and animals in which the epigenomic elements NRs, PGC-1α and β, and the Sirtuins are inactivated,

Perspective

The similarity in symptoms between mitochondrial and epigenomic diseases suggests that they have a common pathophysiology. Is so, alterations in mitochondrial function will have important effects on the epigenome and alterations in the epigenome will have significant effects on mitochondrial function (Borrelli et al., 2008).

The epigenome has been hypothesized to provide the interface between the environment and the regulation of nDNA gene expression (Feinberg, 2007, Feinberg, 2008). The most

Acknowledgments

The authors would like to thank Ms. Marie T. Lott for her assistance in assembling this document. The work has been supported by NIH Grants NS21328, AG24373, DK73691, AG13154, AG16573, a CIRM Comprehensive Grant RC1-00353-1, a Doris Duke Clinical Interfaces Award 2005, and an Autism Speaks High Impact Grant awarded to DCW and a CIRM Predoctoral Fellowship awarded to WF.

References (267)

  • D. Figarella-Branger et al.

    Defects of the mitochondrial respiratory chain complexes in three pediatric cases with hypotonia and cardiac involvement

    Journal of the Neurological Sciences

    (1992)
  • S.M. Fuchs et al.

    Protein modifications in transcription elongation

    Biochimica et Biophysica Acta

    (2009)
  • N. Fuku et al.

    Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians

    American Journal of Human Genetics

    (2007)
  • G. Galiova et al.

    Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A

    European Journal of Cell Biology

    (2008)
  • A. Goel et al.

    Glucose metabolism in cancer. Evidence that demethylation events play a role in activating type II hexokinase gene expression

    The Journal of Biological Chemistry

    (2003)
  • P. Gulati et al.

    Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34

    Cell Metabolism

    (2008)
  • M.C. Haigis et al.

    SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells

    Cell

    (2006)
  • A.M. Hakelien et al.

    Expression of the myodystrophic R453W mutation of lamin A in C2C12 myoblasts causes promoter-specific and global epigenetic defects

    Experimental Cell Research

    (2008)
  • C.M. Hale et al.

    Dysfunctional connections between the nucleus and the actin and microtubule networks in laminopathic models

    Biophysical Journal

    (2008)
  • C.J. Hong et al.

    Association study of polymorphisms in the mitochondrial aspartate/glutamate carrier SLC25A12 (aralar) gene with schizophrenia

    Progress in Neuro-Psychopharmacology and Biological Psychiatry

    (2007)
  • S. Huang et al.

    Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A

    Experimental Cell Research

    (2008)
  • D.I. James et al.

    HFis1, a novel component of the mammalian mitochondrial fission machinery

    The Journal of Biological Chemistry

    (2003)
  • D.P. Jones

    Disruption of mitochondrial redox circuitry in oxidative stress

    Chemico-Biological Interactions

    (2006)
  • S. Ahmed et al.

    Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress

    Journal of Cell Science

    (2008)
  • B.H. Ahn et al.

    A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis

    Proceedings of the National Academy of Sciences of the United States of America

    (2008)
  • B. Alberts et al.

    Molecular Biology of the Cell

    (2002)
  • R.E. Amir et al.

    Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

    Nature Genetics

    (1999)
  • A.L. Andreu et al.

    A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria

    Annals of Neurology

    (1999)
  • A.L. Andreu et al.

    Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy

    Neurology

    (1998)
  • A.L. Andreu et al.

    Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA

    New England Journal of Medicine

    (1999)
  • D. Araujo-Vilar et al.

    A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy

    Clinical Endocrinology (Oxford)

    (2008)
  • R.K. Bai et al.

    Mitochondrial genetic background modifies breast cancer risk

    Cancer Research

    (2007)
  • J.A. Baur et al.

    Resveratrol improves health and survival of mice on a high-calorie diet

    Nature

    (2006)
  • J.A. Baur et al.

    Therapeutic potential of resveratrol: the in vivo evidence

    Nature Reviews Drug Discovery

    (2006)
  • E.G. Bechara et al.

    A novel function for fragile X mental retardation protein in translational activation

    PLoS Biology

    (2009)
  • F. Bellomo et al.

    Regulation by the cAMP cascade of oxygen free radical balance in mammalian cells

    Antioxidants and Redox Signaling

    (2006)
  • H.T. Bjornsson et al.

    Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors

    Journal of the National Cancer Institute

    (2007)
  • G. Boily et al.

    SirT1 regulates energy metabolism and response to caloric restriction in mice

    PLoS One

    (2008)
  • L.M. Booker et al.

    North American white mitochondrial haplogroups in prostate and renal cancer

    Journal of Urology

    (2006)
  • M. Brandon et al.

    Mitochondrial mutations in cancer

    Oncogene

    (2006)
  • M.D. Brown et al.

    The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup

    J Human Genetics

    (2002)
  • M.D. Brown et al.

    Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage

    American Journal of Human Genetics

    (1997)
  • M.D. Brown et al.

    Phylogenetic analysis of Leber’s hereditary optic neuropathy mitochondrial DNA’s indicates multiple independent occurrences of the common mutations

    Human Mutation

    (1995)
  • S. Cai et al.

    SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes

    Nature Genetics

    (2006)
  • M. Caron et al.

    Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence

    Cell Death and Differentiation

    (2007)
  • G. Carrieri et al.

    Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer’s disease

    Human Genetics

    (2001)
  • R. Carrozzo et al.

    SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness

    Brain

    (2007)
  • P. Chagnon et al.

    Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French–Canadian founder population

    American Journal of Medical Genetics

    (1999)
  • C. Chen et al.

    TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species

    The Journal of Experimental Medicine

    (2008)
  • H. Chen et al.

    Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development

    Journal of Cell Biology

    (2003)
  • Cited by (405)

    View all citing articles on Scopus
    View full text